Quantcast
Home > Quotes > OPK

OPKO Health, Inc. Common Stock (OPK) Quote & Summary Data

OPK 
$4.32
*  
unch
unch
Get OPK Alerts
*Delayed - data as of Sep. 21, 2018  -  Find a broker to begin trading OPK now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    OPK After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 4.31 / $ 4.35
1 Year Target
8.5
Today's High / Low
$ 4.41 / $ 4.25
Share Volume
13,239,313
50 Day Avg. Daily Volume
6,032,844
Previous Close
$ 4.32
52 Week High / Low
$ 7.24 / $ 2.66
Market Cap
2,418,210,698
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.55
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.52

Intraday Chart

News for OPK

Shares Traded

Share Volume:
13,239,313
50 Day Avg. Daily Volume:
6,032,844

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.55

Trading Range

The current last sale of $4.32 is 62.41% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 4.41 $ 7.24
 Low: $ 4.25 $ 2.66

Company Description (as filed with the SEC)

We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our diagnostics business includes BioReference Laboratories ("BioReference"), the nation's third-largest clinical laboratory with a core genetic testing business and an almost 400-person sales and marketing team to drive growth and leverage new products, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform (in development).  ... More ...  


Risk Grade

Where does OPK fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 4.30
Open Date:
Sep. 21, 2018
Close Price:
$ 4.32
Close Date:
Sep. 21, 2018

Consensus Recommendation

Analyst Info